trial · primary record
Tabirafusp tedromer
Diabetic Macular Edema (DME)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 910 |
| Primary completion | 2029-09 |
| Primary endpoint | Best corrected visual acuity (BCVA) |
| Registry ID | NCT07734844 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:29.754Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07734844
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.